Clinical Trial

Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn about the effect of the study drug acetazolamide in individuals with Type 1 Diabetes. Specifically, whether acetazolamide provides benefits to the kidneys while minimizing any side effects of the drug. These changes will be measured by laboratory tests that tell us how well the kidneys are functioning.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-12.
Trial Details
NCT Number NCT06981234
Lead Sponsor University of California, San Diego
Collaborators: Breakthrough T1D
Conditions Type 1 Diabetes
Enrollment 25 participants
Start Date 2024-08-14
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-06-17